CRISPR/ Gene editing
Small molecules such as 4-Hydroxytamoxifen ≥70% Z isomer can enhance the overall efficiency and targeting precision of CRISPR/Cas-9-mediated genome editing. Researchers can save up to 50% on small molecules for CRISPR / Cas9 genome editing - they are up to half the price of other suppliers.
View resources: Small Molecules for Genome Editing | Inducible CreER and CRISPR/Cas9 genome engineering techniques using small molecules
(S)-3,5-DHPG (HB0045)
Description:Selective group I mGlu receptor agonist. Induces LTD.
Purity:>99%
DMNQ (HB3876)
Description:Cell-permeable, redox cycling quinone. Induces ROS generation.
Purity:>99%
- Description:
Effective agonist for muscarinic-based DREADDs in vitro and in vivo. Non-CNO chemogenetic actuator. Brain penetrant. Water soluble.
Purity:>98%
DREADD agonist 21 (Compound 21) (HB4888)
Description:Effective agonist for muscarinic-based DREADDs in vitro and in vivo. Non-CNO chemogenetic actuator. Brain penetrant.
Purity:>98%
DY131 (HB2491)
Description:Novel selective estrogen-related receptor ERRβ and ERRγ agonist
Purity:>99%
1-EBIO (HB1045)
Description:Epithelial KCa channel activator. Promotes ESC differentiation into cardiomyocytes.
Purity:>98%